29 February 2024


…TIMESLOT: 29 fev. 2024 16:00 CET

…THEME: Rhabdomyolysis​

…PRESENTER: Prof. Antonio Toscano (University of Messina, Italy)

…BIOSKETCH: PROF. ANTONIO TOSCANO, M.D., born 16/12/1956 in Messina, Italy Full Professor of Neurology, University of Messina, Italy at the AOU Policlinico “G. Martino”, Department of Clinical and Experimental Medicine, Neurology and Neuromuscular disorders Unit, Via Consolare Valeria, 1 – 98125, Messina, Italy DEGREE in Medicine (M.D.): 1981 FIELD OF STUDY: MedicinernSince 1982, he is a member of the Medical Professional Order of the Province of Messina (n° 4743) DEGREE: Specialization in Neurology (4 years) (M.D.) 1985 (four years) 1986-1987 Post-doctoral Fellow, at the University of London, UK at the “The National Hospital for Nervous Diseases”, Queen Square, London, working with Dr. J. A Morgan-Hughes and with J.B. Clark at the Department of Biochemistry of S. Bartholomew’s Medical College on “Mitochondrial disorders” 1988 Post-doctoral Fellow, with a fellowship for a project on “Mitochondrial disorders” at “The National Hospital for Nervous diseases”, London U.K, funded by ESF (European Society Foundation) of Strasbourg, working with dr. J.A: Morgan-Hughes 1989 Post-doctoral fellow at the University of Messina, ItalyrnFellowship for “Studies on animal models with traumatic neuropathies”rnNeurology/Veterinary Units, University of Messina, Italy 1990-2000 Assistant Professor, Department of Neurology, Psychiatry and Anaesthesiology, University of Messina, Italy 2000-2008 Associate Professor, Department of Neurology, Psychiatry and Anaesthesiology, University of Messina, Italy 2009 – to now Full Professor of Neurology, Department of Clinical and Experimental Medicine, University of Messina, Italy 2011- Director of the Regional Reference Center for Rare Neuromuscular Disorders, Department of Neurosciences, AOU Policlinico “G. Martino”, Messina Italy YEAR: 1998 Membership of ENS INVOLVEMENT: 1998 – to 2013 Member of the ENS Subcommittee for Neuromuscular DisordersrnChairman and speaker for several years for the Neuromuscular Teaching Courses Since 2009 to 2013, reviewer of abstracts on Muscle disorders and Neurogenetics for ENS meetingsrnMembership of European Academy of Neurology (EAN) Since 2013, active elected member of the general Assembly of the European Academy of Neurology (EAN) Since 2014, Member of the EAN Scientific Committee (SC)rnSince the same year, member of the EAN Muscle disorders panel Since 2015 to 2018, appointed EAN SC member for Rare Diseases Since 2016, Chairman of the EAN panel on Muscle disorders Honors Member of various scientific Italian and International Societies (SIN, AIM, ASNP, EAN, WMS) 1996-2000 Member of the Committee of the Italian Society of Neuropathology 2006-2009 Secretary of the Italian Association of Myology (AIM) 2009-2012 President of the Italian Association of Myology (AIM) 2012-2015 Past President of AIM 2009 to now Member of the World Pompe Global Advisory Board 2011 to now Member of TREAT-NMD Task Force 2013 Honorary Advisory Board Member of SOLANE (Sociedad Latino-Americana Enfermedades Neuromuscolares) 2014 Member of the Scientific Committee of the EAN (European Academy of Neurology) appointed by the EAN President, Prof. G. Deuschl, and by the EAN Scientific Director, prof. A. Federico 2015 Member of the European Pompe Consortium (EPOC) Advisory Board 2015 Member of the Italian Neurological Society (SIN) Advisory Board Editorial Boards He is member of the Editorial Board of: 1) Neuromuscular disorders, 2) Journal of Neuromuscular diseases Reviewer for several scientific journals as NEJM, Neurology, Brain, J. of Neurology, Neuromuscular Disorders, Muscle & Nerve, Acta Neuropathologica, Neurological Sciences, Plos One, Molecular Genetics and Metabolism, Orphanet journal of rare diseases Prof. Toscano scientific activity has been mainly developed in neurogenetic diseases with specific reference to neuromuscular and neurodegenerative disorders In fact, he is particularly dedicated to the diagnosis, management and treament of: 1) Metabolic myopathies as muscle glycogenoses (with particular interest in Glycogenosis type II – Pompe disease), lipid storage myopathies and mitochondrial disorders, 2) Genetic myopathies (limb-girdle syndromes, distal myopathies, channelopathies, cardiomyopathies, congenital myasthenia), 3) Peripheral neuropathies (particularly, disimmune and genetic neuropathies) 4) Neurodegenerative diseases (i.e., cerebellar ataxias and spastic paraparesis). He is also author of over 160 publications in indexed journals (see list of pubblications).

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern